Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Paediatric Anaesthesia|January 5, 2011
Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 monthsAnne M Lynn, Heidi Bradford, Eric D Kantor, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonistRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
British Journal of Pharmacology|February 25, 2024
Characterisation of cotadutide's dual GLP-1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology modelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2009
Pharmacokinetic-pharmacodynamic and response sensitization modeling of the intraocular pressure-lowering effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)Kenneth T Luu, Eric Y Zhang, Ganesh Prasanna, et al.
Journal of Clinical Pharmacology|October 18, 2008
Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology GroupJeannine S McCune, David H Salinger, Paolo Vicini, et al.
Pharmacogenetics and Genomics|November 3, 2009
Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulationDavid H Salinger, Danny D Shen, Kenneth Thummel, et al.
The Journal of Pharmacy and Pharmacology|December 1, 2022
The manufacturing of 3D-printed microfluidic chips to analyse the effect upon particle size during the synthesis of lipid nanoparticlesEdward Weaver, Essyrose Mathew, Jay Caldwell, et al.
Drug Delivery and Translational Research|July 28, 2023
Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticlesEdward Weaver, Federica Sommonte, Andrew Hooker, et al.
Clinical Pharmacokinetics|June 22, 2005
Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studiesEvan D Kharasch, Dale Whittington, Christine Hoffer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2011
Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environmentErik Sjögren, Joakim Nyberg, Mats O Magnusson, et al.
Pageof 11